Finance
RegeneRx closes $9.55 million offering of common stock
Published in Biotech Business Week, January 22nd, 2007
The company sold 5,305,557 shares of common stock at $1.80 per share for aggregate gross proceeds of $9.55 million. Participants in the financing included several new institutional investors as well as existing investors and affiliates of Sigma-Tau Group, the company's largest stockholder. In addition, warrants to purchase 2,122,222 shares of common stock were issued to the investors. The warrants have an exercise price of $2.75 per share. Piper Jaffray & Co. acted as sole placement agent for the transaction.
"We are pleased that several of our existing...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
More Articles from Biotech Business Week
- Market Analysis
Blossoming in vitro diagnostics market in India surpasses $250 million in 2006 - Market Analysis
Report provides comprehensive facts and figures for protein therapeutics market - Market Analysis
Research and Markets releases market report on types of available RNAi-testing technologies - Market Analysis
Research and Markets releases report on nuclear cardiology markets - Acne Vulgaris
Research from Corixa Corporation provide new insights into acne vulgaris - Allergies Immunology
Studies from Millennium Pharmaceuticals yield new information about allergies immunology - More from this issue of Biotech Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
